• 한국독성학회:학술대회논문집
• /
• 한국독성학회 2001년도 International Symposium on Signal transduction in Toxicology
• /
• pp.121-121
• /
• 2001

Thioacetamide has been known to cause immune suppression. In this report we studied the role of metabolic activation by flavin-containing monooxygenase in the thioacetamide-induced immune response. To determine whether the metabolites of thioacetamide produced by flavin-containing monooxygenase result in the immunosuppression, methimazole, a flavin-containing monooxygenase inhibitor, was used to block the flavin-containing monooxygenase pathway.(omitted)

• Environmental Analysis Health and Toxicology
• /
• 제15권4호
• /
• pp.139-145
• /
• 2000

FMO (Flavin-containing Monooxygenase, EC1.14.13.8)는 다양한 종류의 식품, 약물이나 기타 외래 유래물질(xenobiotics)을 산화시키는 NADPH와 $O_2$의존성 약물대사 효소이다 현재까지 5종의 subfamility가 존재하는 것으로 보고되어지고 있으며 그 중 가장 잘 알려진 FMO3는 대표적인 subfamility로서 주로 간에 존재한다. 사람 FMO에 관한 연구는 최근들어 활성화되기 시작했으며 질소, 황이나 인 등을 포함하는 친핵성 (nucleophilic)화합물이 대표적인 기질로 보고되어 있다. 본 연구에서는 항 산화작용이 있는 것으로 알려진 selenium을 포함하고 있는 화합물에 대한 사람의 FMO3의 기질특이성을 알아보고자 하였다. 사람 FMO3를 baculovirus system을 이용하여 발현시킨 후 그 microsomal FMO3을 이용하여 thiochline assay를 시행하였다. 그 결과 기질의 크기에 따라 활성의 차이가 있었으며 크기가 작은 selenium화합물은 기존의 질소나 인 등을 포함하는 기질보다 더 낮은 $K_{m}$ 값을 보였다.

• Environmental Analysis Health and Toxicology
• /
• 제16권2호
• /
• pp.97-102
• /
• 2001

FMOs (Flavin-containing monooxygenases, EC1.14.13.8)는 다양한 종류의 식품, 약물이나 기타 외래 유래물질 (xenobiotics)를 산화시키는 NADPH와 $O_2$ 의존성 약물대사효소이다. 현재까지 5종의 subfamily가 존재하는 것으로 보고되어 있으며 그 중 잘 알려진 FMO3는 대표적 인 subfamily로서 주로 간에 존재한다 사람FMO에 관한 연구는 최근 들어 활성화되기 시작했으며 질소, 황이나 인 등을 포함하는 친핵성 (nucleophilic) 화합물이 대표적인 기질로 보고되어 있다. 본 연구에서는 thiocarbamide를 포함하고 있는 화합물에 대한 사람의 FMO3의 기질 특이성을 알아보고자 하였다. 사람 FMO3를 baculovirus system을 이용하여 대량으로 발현시킨 후 그 microsomal FMO3를 분리하여 thiocholine assay를 시행하였다. 그 결과 methimazole, thiourea, and phenylthiourea는 낮은 $K_{m}$ (4-10$\mu$M)간을 갖는 반면, 이보다 기질의 크기가 큰 1 ,3-diphenylthiourea, 1, 3-bis (3, 4-dichlorophenyl)-2-thiourea, 1, 1-dibenzyl-3-phenol-2-thiourea에서는 효소활성이 나타나지 않았다. 이는 사람 fM01과 비교하여 볼 때 큰 차이는 없었으며, 다른 pig, guinea pig, rat, rabbit에서 보다 받아들일 수 있는 기질의 크기가 더 제한적임을 알 수 있었다.

• 한국환경성돌연변이발암원학회:학술대회논문집
• /
• 한국환경성돌연변이발암원학회 2002년도 Current Trends in Toxicological Sciences
• /
• pp.73-73
• /
• 2002

• 한국독성학회:학술대회논문집
• /
• 한국독성학회 2002년도 Current Trends in Toxicological Sciences
• /
• pp.73-73
• /
• 2002

Thioacetamide has been known to cause immune suppression. The object of the present study is to investigate the role of metabolic activation by flavin- containing monooxygenases (FMO) in thioacetamide-induced immune response. To determine whether the metabolites of thioacetamide produced by FMO causes the immunosuppression, methimazole (MMI), an FMO inhibitor, was used to block the FMO pathway.(omitted)

• The Korean Journal of Physiology and Pharmacology
• /
• 제1권5호
• /
• pp.591-595
• /
• 1997

An ex vivo assay determining the flavin-containing monooxygenase (FMO) activity in perfused rat liver has been developed by assessing the rate of thiobenzamide S-oxide (TBSO) formation from the infused thiobenzamide (TB). The hepatotoxicity by TB or TBSO was not a critical factor for maintaining the FMO activity for up to 50 min. The FMO activity expressed in nmoles TBSO produced/g liver/min was the same for the recycling and non-recycling perfusion. This implies that reduction of the oxidized TBSO back to the parent compound (TB) is negligible. Hydrolysis of the collected perfusates with either ${\beta}-glucuronidase$ or arylsulfatase did not increase the TBSO level and thus, TBSO does not appear to undergo conjugation either to glucuronide or sulfate esters. Thus, measuring the rate of TB S-oxidation in the isolated perfused liver with 1 mM TB for 50 min provides a useful tool for evaluation of the hepatic FMO activity in the absence of hepatic necrosis and without the interferences caused by further conjugation or back reduction of the TBSO to the parent TB.

• 한국식품위생안전성학회지
• /
• 제14권4호
• /
• pp.415-421
• /
• 1999

The flavin-containing monooxygenases (FMOs) (EC 1.14. 13.8) are NADPH-dependent flavoenzymes that catalyze oxidation of soft nucleophilic heteroatom centers in a range of structurally diverse compounds including foods, drugs, pesticides, and other xenobiotics. In humans, FMOl appears to be the predominant form expressed in human fetal liver. cDNA-expressed human FMO and human liver microsomal FMO have been observed to N- and S-oxy-genate nucleophilic nitrogen- and sulfur-containing drugs and chemicals, respectively. In the present study, FMOl can be expressed in the baculovirus expression vector system at level of 2.68 nmol FMOl/mg of membrane protein. This isoform was examined for its capacity to metabolize methimazole to its S-oxide using thiocholine assay. Kinetic studies of its S-oxide by recombinant human FMO1 result in Km of 7.66 $\mu$M and Vmax of 17.79 nmol/min/mg protein.

• The Korean Journal of Physiology and Pharmacology
• /
• 제7권3호
• /
• pp.157-162
• /
• 2003

Our earlier studies found a significant correlation between the activities of ranitidine N-oxidation catalyzed by hepatic flavin-containing monooxygenase (FMO) and the presence of mutations in exon 4 (E158K) and exon 7 (E308G) of the FMO3 gene in Korean volunteers. However, caffeine N-1 demethylation (which is also partially catalyzed by FMO) was not significantly correlated with these FMO3 mutations. In this study, we examined another common mutation (V257M) in exon 6 of FMO3 gene. The V257M variant, which is caused by a point mutation (G769A), was commonly observed (13.21% allele frequency) in our subjects (n=159). This point mutation causes a substitution of $Val^{257}$ to $Met^{257}$, with transformation of the secondary structure. The presence of this mutant allele correlated significantly with a reduction in caffeine N-1-demethylating activity, but was not correlated with the activity of N-oxidation of ranitidine. In a family study, the low FMO activity observed in a person heterozygous for a nonsense mutation in exon 4 (G148X) and heterozygous for missense mutation in exon 6 (V257M) of FMO3 was attributed to the mutations. Our results suggest that various point mutations in the coding regions of FMO3 may influence FMO3 activity according to the probe substrates of varying chemical structure that correlate with each mutation on the FMO3 gene.

• 대한임상약리학회:학술대회논문집
• /
• 대한임상약리학회 1999년도 제8차 추계학술대회 및 정기총회
• /
• pp.30-30
• /
• 1999

• The Korean Journal of Physiology and Pharmacology
• /
• 제8권4호
• /
• pp.213-218
• /
• 2004

Primary fish-odor syndrome (FOS) is a genetic disorder caused by defective flavin-containing mono-oxygenase 3 gene (FMO3) with deficient N-oxidation of trimethylamine (TMA), causing trimethylaminuria (TMAU). By contrast, secondary FOS can be acquired by decreased FMO activities in patients with chronic liver diseases, but the underlying mechanisms are unknown. In the present study, we examined plasma NOx concentrations and viral DNA contents as well as in vivo FMO activities and their correlations in chronic viral hepatitis (CVH) patients. Plasma concentration of NOx was significantly increased by 2.1 fold $(56.2{\pm}26.5\;vs.\;26.6{\pm}5.4\;{\mu}M,\;p<0.01)$, and it was positively correlated with plasma hepatitis B virus (HBV) DNA contents $(r^2=0.2838,\;p=0.0107)$. Furthermore, the elevated plasma NOx values were inversely and significantly correlated with in vivo FMO activities detected by ranitidine-challenged test $(8.3%\;vs.\;20.0%,\;r^2=0.2109,\;p=\0.0315)$. TMA N-oxidation activities determined in CVH patients without challenge test were also significantly low (73.6% vs. 95.7%, p< 0.05). In conclusion, these results suggested that secondary FOS could be acquired by the endogenously elevated NO in patients with CVH.